Concanavalin A-induced T-cell-Mediated hepatic injury in mice: The role of tumor necrosis factor

Hepatology

Volumn 21, Issue 1, 1995, Pages 190-198

  Gantner, Florian ^a   Leist, Marcel ^a   Lohse, Ansgar Wilhelm ^b   Germann, Paul Georg ^c   Tiegs, Gisa ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c ALTANA PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CONCANAVALIN A; CYCLOSPORIN A; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL TRANSFER; CONTROLLED STUDY; IMMUNOPATHOGENESIS; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; LIVER PROTECTION; LYMPH NODE CELL; MALE; NONHUMAN; PREVENTION; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ANIMAL; APOPTOSIS; CELLS, CULTURED; CONCANAVALIN A; FLUORESCEIN-5-ISOTHIOCYANATE; IMMUNE SERA; IMMUNOCOMPETENCE; LIVER; LYMPH NODES; MALE; MICE; MICE, INBRED STRAINS; MICE, NUDE; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR;

EID: 0028795171     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90428-X     Document Type: Article

References (62)

1. T cell-mediated lethal shock triggered in mice by the superantigen Staphylococcal enterotoxin B: critical role of tumor necrosis factor
2. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants
3. Pentoxifylline suppresses OKT3-induced tumor necrosis factor alpha formation in renal transplant recipients
4. Inhibition of endogenous TNF formation by pentoxifylline
5. Cytokine related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation
6. Superantigens
7. Staphylococcal intoxications
8. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome
9. Superantigens in human diseases
10. Evidence for the effects of a superantigen in rheumatoid arthritis
11. A T cell-dependent experimental liver injury in mice inducible by concanavalin A
12. Biological properties of lectins
13. Alanine aminotransferase
14. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor tumor necrosis factor from human monocytes
15. An improved colorimetric assay for interleukin 2
16. Simple, sensitive and specific bioassay of interleukin-1
17. Preparation of rat liver cells: Enzymatic requirements for tissue dispersion
18. Mouse liver cell culture-I. Hepatocyte isolation
19. Endotoxin-inducible cytotoxicity in liver cell cultures-I
20. Cytokines coordinators of immune and inflammatory responses
21. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
22. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
23. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody
24. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNFa in galactosamine-sensitized mice
25. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
26. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease
27. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
28. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
29. Circulating levels of interleukin la, tumor necrosis factor, interferon y and soluble interleukin-2 receptor are high in children with autoimmune chronic liver disease
30. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/ nitrate biosynthesis while promoting hepatic damage
31. Inhibition of Corynebacterium parvum-primed and lipopolysaccharideinduced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody
32. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum
33. Immunohistochemical detection of TNF-a and IFN-y in the liver of children with autoimmune chronic active hepatitis and primary cholangitis
34. A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days
35. Murine hepatocyte apoptosis induced in vitro and in vivo by TNFa requires transcriptional arrest
36. Tumor-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits
37. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells
38. Induction of interleukin-2 messenger RNA inhibited by Cyclosporine A
39. Inhibition of cytokine production by Cyclosporine A and transforming growth factorβ
40. Cyclosporine A inhibits TNF production without decreasing TNF mRNA levels
41. A novel addition to the T cell repertory
42. + T cell clones provides a costimulatory signal for human B cell activation
43. Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/ cachectin
44. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF
45. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes
46. Tumor necrosis, cachexia, shock, and inflammation: a common mediator
47. IFN-y and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells
48. Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism
49. Production of interleukin-1α, interleukin-1β and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor
50. Regulation of tumor necrosis factor (TNF) expression: interferon-y enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages
51. Gamma interferon enhances macrophage transcription of the tumor necrosis/cachectin interleukin-1 and urokinase genes which are controlled by short-lived repressors
52. Heterogenous effects of IFN-γ in adjuvant arthritis
53. Anti-interferon-y antibody protects mice against the generalized Shwartzman reaction
54. The role of IFN-y in the pathology of experimental endotoxemia
55. Monoclonal antibody against interferon y can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor
56. Potentiation by GM-CSF of LPS toxicity in mice
57. Regulation of lymphocyte tumor necrosis factor receptors by IL-2
58. Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity
59. Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor
60. Four different interleukin-1 species sensitize to the lethal action of tumor necrosis factor
61. Tumor necrosis factor/cachectin as an effector of T cell-dependent immunopathology